Search for: "R-R Drugs, Inc." Results 1 - 20 of 5,177
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Apr 2024, 1:07 pm by Bevin Newman
The Federal Trade Commission (“FTC”) has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. [read post]
26 Mar 2024, 7:01 pm by Kurt R. Karst
  Late last week, the FTC submitted an Amicus Brief in recent Hatch-Waxman patent litigation in the District Court of New Jersey between Reference Listed Drug holder Teva Branded Pharmaceutical Products R&D Inc. and ANDA applicant Amneal Pharmaceuticals explaining that patents that claim the device constituent of a combination product but do not expressly claim the relevant drug substance should not be listed in the Orange Book. [read post]
25 Jan 2024, 5:31 am by Ashley Morgan
Once the FDA approves a drug, it means that the agency has found that (1) the drug is safe and effective for its intended use, and (2) the benefits of using the drug outweigh the risks as long as the drug is used as intended, according to its approved labeling. [read post]
31 Dec 2023, 4:00 am by Administrator
The dog signalled that drugs were present and the accused was arrested for possession of a controlled substance. [read post]
29 Nov 2023, 8:41 am by Dennis Crouch
The Federal Circuit rejected this argument based on dicta in Thryv, Inc. v. [read post]